Identification of novel cardiovascular disease associated metabolites using untargeted metabolomics

Area of Science:

• Biochemistry
• Metabolomics
• Cardiovascular Research

Background:

• Cardiovascular disease (CVD) is a major global health concern, causing significant morbidity and mortality.
• Early diagnosis of CVD is crucial for effective management and improved patient outcomes.

Purpose of the Study:

• To identify novel serum metabolites associated with cardiovascular disease (CVD) using an untargeted metabolomic approach.
• To explore the potential of these metabolites as diagnostic biomarkers or therapeutic targets for CVD.

Main Methods:

• Employed an untargeted metabolomic strategy to analyze serum samples from CVD patients and healthy individuals.
• Utilized statistical analysis to identify significantly differential metabolites.
• Performed pathway enrichment analysis to understand the metabolic context of identified metabolites.

Main Results:

• Identified 26 unique metabolites differentially present in CVD patients, with 15 reaching statistical significance.
• Discovered novel metabolites, including UDP-l-rhamnose and N1-acetylspermidine, not previously linked to CVD.
• Found that metabolites such as ethanolamide and dimethylarginine can discriminate CVD.
• Pathway analysis revealed enrichment in histidine metabolism, methyl histidine metabolism, carnitine synthesis, and arginine/proline metabolism in CVD patients.

Conclusions:

• The study successfully identified unique and novel metabolites associated with cardiovascular disease.
• These identified metabolites and enriched pathways offer new insights into CVD pathophysiology.
• The findings present opportunities for developing CVD-specific biomarkers and therapeutic strategies.